resveratrol has been researched along with Left Ventricular Hypertrophy in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Y; He, T; Zhang, J; Zhang, Z | 1 |
| Esmaili Dahej, M; Hafizi Barjin, Z; Moradi, A; Safari, F; Soltan, F; Yadegari, M | 1 |
| Chan, AY; Dolinsky, VW; Dyck, JR; Nagendran, J; Rogan, KJ; Soltys, CL; Wang, S | 1 |
| Chan, AY; Des Rosiers, C; Dolinsky, VW; Dyck, JR; Light, PE; Robillard Frayne, I | 1 |
| Calamaras, TD; Cohen, RA; Colucci, WS; Higuchi, A; Hou, X; Luptak, I; Miller, EJ; Ouchi, N; Qin, F; Siwik, DA; Tu, VH; Verbeuren, TJ; Walsh, K; Wang, L; Weisbrod, RM | 1 |
| Das, DK; Juric, D; Netticadan, T; Wojciechowski, P | 1 |
6 other study(ies) available for resveratrol and Left Ventricular Hypertrophy
| Article | Year |
|---|---|
Activation of SIRT1 by Resveratrol Alleviates Pressure Overload-Induced Cardiac Hypertrophy via Suppression of TGF-β1 Signaling.
Topics: Animals; Cardiomegaly; Disease Models, Animal; Fibrosis; Hemodynamics; Hypertrophy, Left Ventricular; Male; Muscle Cells; Random Allocation; Rats; Rats, Sprague-Dawley; Resveratrol; Sirtuin 1; Smad3 Protein; Transforming Growth Factor beta1; Ventricular Function | 2021 |
Resveratrol Confers Protection Against Ischemia/Reperfusion Injury by Increase of Angiotensin (1-7) Expression in a Rat Model of Myocardial Hypertrophy.
Topics: Angiotensin I; Animals; Disease Models, Animal; Hypertrophy, Left Ventricular; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Peptide Fragments; Proto-Oncogene Mas; Rats, Wistar; Resveratrol; Tachycardia, Ventricular; Ventricular Fibrillation | 2021 |
Resveratrol prevents pathological but not physiological cardiac hypertrophy.
Topics: AMP-Activated Protein Kinases; Animals; Antioxidants; Cells, Cultured; Exercise; Heart Ventricles; Humans; Hypertrophy, Left Ventricular; Insulin-Like Growth Factor I; Mice, Inbred C57BL; Myocytes, Cardiac; NFATC Transcription Factors; Rats; Resveratrol; Ribosomal Protein S6 Kinases, 70-kDa; Signal Transduction; Stilbenes; Transcriptional Activation; Ventricular Function | 2015 |
Resveratrol prevents the prohypertrophic effects of oxidative stress on LKB1.
Topics: Aldehydes; AMP-Activated Protein Kinase Kinases; AMP-Activated Protein Kinases; Animals; Cardiomegaly; Cells, Cultured; Hypertension; Hypertrophy, Left Ventricular; Lipid Peroxidation; Myocytes, Cardiac; Oxidative Stress; Protein Kinases; Protein Serine-Threonine Kinases; Rats; Rats, Inbred SHR; Resveratrol; Ribosomal Protein S6 Kinases, 70-kDa; Signal Transduction; Stilbenes; TOR Serine-Threonine Kinases | 2009 |
The polyphenols resveratrol and S17834 prevent the structural and functional sequelae of diet-induced metabolic heart disease in mice.
Topics: Adiponectin; Animals; Antihypertensive Agents; Benzopyrans; Diastole; Diet, High-Fat; Dietary Carbohydrates; Hypertrophy, Left Ventricular; Insulin Resistance; Male; Mice; Mice, Inbred C57BL; Protein Processing, Post-Translational; Resveratrol; Stilbenes; Ventricular Function, Left | 2012 |
Prevention of concentric hypertrophy and diastolic impairment in aortic-banded rats treated with resveratrol.
Topics: Animals; Aorta; Dose-Response Relationship, Drug; Hypertension; Hypertrophy, Left Ventricular; Male; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Resveratrol; Stilbenes; Stroke Volume; Treatment Outcome; Ultrasonography; Vasodilator Agents; Ventricular Dysfunction, Left | 2007 |